1. Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
    Victor G. Martinez et al, 2019, Frontiers in Genetics CrossRef

  2. DUB3 Facilitates Growth and Inhibits Apoptosis Through Enhancing Expression of EZH2 in Oral Squamous Cell Carcinoma


    Fei Luo et al, 2020, OncoTargets and Therapy CrossRef
  3. The bromodomain and extra-terminal domain inhibitor JQ1 synergistically sensitizes human colorectal cancer cells to topoisomerase I inhibitors through repression of Mre11-mediated DNA repair pathway
    Linping Lei et al, 2021, Investigational New Drugs CrossRef
  4. Privileged Scaffolds Targeting Bromodomain-containing Protein 4
    Ru Wang et al, 2022, Current Topics in Medicinal Chemistry CrossRef
  5. From Therapy Resistance to Targeted Therapies in Prostate Cancer
    Filipa Moreira-Silva et al, 2022, Frontiers in Oncology CrossRef
  6. Physachenolide C is a Potent, Selective BET Inhibitor
    Christopher J. Zerio et al, 2023, Journal of Medicinal Chemistry CrossRef
  7. High Expression Level of BRD4 Is Associated with a Poor Prognosis and Immune Infiltration in Esophageal Squamous Cell Carcinoma
    Li Li et al, 2023, Digestive Diseases and Sciences CrossRef
  8. Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patients
    Marta Sanz-Álvarez et al, 2021, Cancers CrossRef
  9. BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4
    Hae In Choi et al, 2021, Scientific Reports CrossRef
  10. MiR-21-3p Plays a Crucial Role in Metabolism Alteration of Renal Tubular Epithelial Cells during Sepsis Associated Acute Kidney Injury via AKT/CDK2-FOXO1 Pathway
    Zhuoyong Lin et al, 2019, BioMed Research International CrossRef
  11. A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
    Zijun Zhou et al, 2020, Frontiers in Pharmacology CrossRef
  12. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer
    Daojun Lv et al, 2021, Frontiers in Surgery CrossRef